A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Oral HRS5091 in Healthy Subjects and Chronic Hepatitis B Patients

NCT04480294 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

108

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: HRS5091

Sponsor

Jiangsu HengRui Medicine Co., Ltd.